Categories AlphaGraphs, Consumer, Earnings

Conagra Brands (CAG) tops Q1 2021 estimates; stock advances

Conagra Brands’ (NYSE: CAG) earnings and sales in the first quarter of fiscal 2021 surpassed the market’s estimates. Adjusted earnings grew 62.8% to $0.70 per share and sales increased 12.1% to $2.7 billion in Q1. The company’s earnings outlook for the second quarter of 2021 was in line with the analysts’ views. CAG stock rose about 2% in the pre-market trading hours.

Conagra Brands (CAG) Q1 2021 Earnings Infograph

“We exceeded our expectations on net sales, profitability, and de-leveraging, and continued to make investments to ensure the physical availability of our products, maintain momentum with consumers, and build brand health,” said CEO Sean Connolly.

For the second quarter of fiscal 2021, Conagra expects adjusted EPS to be between $0.70 and $0.74. Organic net sales growth is estimated to be in the range of 6% to 8%.

The company reaffirmed its fiscal 2022 algorithm; adjusted EPS of $2.66 to $2.76 and organic net sales growth (3-year CAGR ending fiscal 2022) of 1% to 2%.

Most Popular

CVX Earnings: Chevron reports lower revenue and profit for Q1 2024

Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or

ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up

Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net

CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results

Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top